Trial intelligence / Profile preview

Intraosseous versus intravenous diclofenac for postoperative pain after total knee arthroplasty

ACTRN12622000196741Phase 4Completed

Sponsor
Simon Young
Start
Aug 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-blind trial of diclofenac in acute postoperative pain and knee osteoarthritis (OA) (2 arms), sponsored by Simon Young. Primary endpoint: Mean pain score by 100 mm visual analogue scale. Started Aug 2022; status: completed.

02

Drugs

diclofenac
03

Conditions

acute postoperative painknee osteoarthritis (OA)

Beyond the preview

Go deeper on ACTRN12622000196741.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12622000196741.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call